Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Thursday 25 April at 4:30pm because of system upgrades. We expect to open them again on Friday 26 April at 8am the latest.

Predictive Toxicology Contract Research Organisation and Infrastructure Development

Reference number
Coordinator Karolinska Institutet - Institutet för miljömedicin
Funding from Vinnova SEK 1 874 433
Project duration December 2015 - November 2018
Status Completed
Venture Eurostars

Purpose and goal

The vision of transforming chemical and drug safety testing relies on the application of computational methods along with data from in vitro cellular models. To this end, Predictive Toxicogenomics Space (PTGS) leveraged large-scale “Big Data” analyses tools are broadly useful for preclinical safety testing of diverse agents. Partner KI has a completed product under the ToxHQ umbrella able to predict drug-induced liver injury in humans. Overall, KI has also made breakthroughs in PTGS-based analysis for more precise delineation of agents’ toxic modes of action and similarity.

Expected results and effects

KI performed key analyses needed for generating novel toxicogenomics tools and successfully adapted them to customer needs as delineated by two large-scale pilot projects with major pharmaceuticals companies developing investigational drugs. Standardized tools can be applied to multiple gene expression platforms and cell-based or in vivo model systems. Services applying the PTGS safety testing concept can be ordered via Predictomics AB, the company established to cooperate within theToxHQ portal and ecosystem, overall aimed at providing external stakeholder services.

Planned approach and implementation

The project was implemented with commercial partners in Sweden and Switzerland. ToxHQ provides an ecosystem for SMEs to deploy sophisticated analysis tools according to customer needs. Partner KI graduated the PTGS analysis tool via diverse validation studies to a high technology/commercial readiness level through extensive pilot projects in broad cooperations within and outside of the project team. KI further established the company Predictomics AB to commercialize the PTGS tool. Standardized workflows and protocols ensure quality and reproducibility of offered analyses.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 4 December 2020

Reference number 2015-04978

Page statistics